Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines

Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines

ID:41189537

大小:1.77 MB

页数:8页

时间:2019-08-18

Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines_第1页
Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines_第2页
Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines_第3页
Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines_第4页
Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines_第5页
资源描述:

《Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库

1、Biomedicine&Pharmacotherapy74(2015)49–56AvailableonlineatScienceDirectwww.sciencedirect.comOriginalArticleInhibitionofproteinglycosylationreversestheMDRphenotypeofcancercelllinesa,*,aaa,bKarolinaWojtowiczRadosławJanuchowski,MichałNowicki,MaciejZabelaDepartmentofHis

2、tologyandEmbryology,PoznanUniversityofMedicalSciences,60-781Poznan,PolandbDepartmentofHistologyandEmbryology,WroclawMedicalUniversity,50-368Wroclaw,PolandARTICLEINFOABSTRACTArticlehistory:Background:Multidrugresistanceproteinsareoneofthemostimportantfactorsthatcaus

3、eReceived12June2015chemotherapyresistance,whichinturnreducestherapeuticefficacyandsurvivalforcancerpatients.Accepted9July2015Tunicamycinisoneofthemostwell-knowninhibitorsofN-glycosylationandisconsideredapowerfuladjunctthatcanincreasetheeffectivenessofmanydrugs.Tunic

4、amycinblocksthefirststepofP-gpKeywords:(glycoproteinP)andBCRP(breastcancerresistanceprotein)N-glycosylation,whichisaveryimportantMultidrugresistancemodificationTunicamycinfortheactivityandcellularlocalisationoftheseproteins.Methods:Theeffectsoftunicamycinonovarianand

5、colorectalcancercellswereexaminedinmultipleChemotherapycelllines.TheprimaryovariancancercelllineW1andtheestablishedovariancancercelllineA2780GlycoproteinPBCRPwerecomparedagainsttheirdrug-resistantderivativesW1TR/W1PR(TR:topotecanresistant;PR:paclitaxelresistant)and

6、A2780T1(topotecanresistant),respectively.WealsocomparedthecolorectalcancercelllineLoVoagainstitsdoxorubicin-resistantderivativeLoVo/Dx.CellviabilitywasdeterminedbytheMTTassay.TheglycopeptidesweresubjectedtodeglycosylationusingtheendoglycosidasePNGaseF.A2780T1,LoVo/

7、DxandW1PRcellsweretreatedwiththeproteindegradationinhibitorsMG132andBMA.Proteinexpressionwasdetectedbywesternblotandimmunocytochemistry.Results:Inthisstudy,weshowedviatheMTTassaythattunicamycinsignificantlydecreasedtheviabilityofcancercelllinesthatwereco-treatedwith

8、achemotherapeuticdrug.Westernblotanalysisshowedthat,inLoVo/DxandW1PRcells,tunicamycintreatmentresultedintheexpressionofa70kDaP-gpproteininsteadof

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。